Structural and Computationally Driven Molecule Design in Drug Discovery: Current Advances and Future Perspectives
Belgin Sever, Hasan DeMirci, Halilibrahim Ciftci · 2026
Read Structural and Computationally Driven Molecule Design in Drug Discovery: Current Advances and Future Perspectives by Belgin Sever, Hasan DeMirci, Halilibrahim Ciftci (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13516275.txt.
Description
Belgin Sever, Hasan DeMirci, and Halilibrahim Ciftci introduce a journal special issue on structure-based drug design in a 2026 editorial. Drug hunting has shifted from trial-and-error toward rational design powered by high-resolution structures, simulations, and artificial intelligence. The collected papers span cancer, infections, brain disease, drug resistance, and metabolic disorders, all sharing computational and structural methods.
A leading theme is structure-guided chemistry against kinases, the signalling enzymes central to many cancers. Highlighted studies build new compound families against the epidermal growth factor receptor, mixing modelling, synthesis, and biological testing to refine leads. Other themes follow the same pattern across the issue's disease areas. The editors argue that combining computation with experiments gives mechanistic insight and speeds the road from molecule to medicine. Readers get a guided map of the issue and of where rational design is heading.
Catalog record
| CREATOR | Belgin Sever, Hasan DeMirci, Halilibrahim Ciftci |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20323 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |